Tvardi Therapeutics Common Stock

Tvardi Therapeutics (TVRD) currently reports a common stock of $9K as of June 2026. That compares with $9K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Tvardi Therapeutics's common stock history and peer comparisons.

Tvardi Therapeutics's common stock was unchanged from $9K to $9K — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tvardi Therapeutics reported $9K in common stock as of June 2026. That compares with $9K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $9K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tvardi Therapeutics, and consider following TVRD for alerts when major investors trade the stock.

Tvardi Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $9K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TVRD with unrelated industries.